(Q37691623)

22 August 2017

1 reference

title

Primary and salvage cryotherapy for prostate cancer (English)

1 reference

22 August 2017

1 reference

3

David C Miller

1 reference

22 August 2017

David S Finley

1

1 reference

22 August 2017

Frederic Pouliot

series ordinal

2

1 reference

22 August 2017

Arie S Belldegrun

series ordinal

4

1 reference

22 August 2017

publication date

1 February 2010

1 reference

Urologic Clinics of North America

22 August 2017

published in

1 reference

22 August 2017

volume

37

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

67-82, Table of Contents

1 reference

Best practice statement on cryosurgery for the treatment of localized prostate cancer

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Salvage prostate cryoablation: initial results from the cryo on-line data registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Issues critical to the successful application of cryosurgical ablation of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

The cryobiology of cryosurgical injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Application of Cryogenic Surgery to Resection of Parenchymal Organs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

7 January 2021

Cryosurgery for tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

The molecular basis of cryosurgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Freezing of living cells: mechanisms and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

The cryobiological basis for cryosurgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Mechanisms of tissue injury in cryosurgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Ice crystals formed in tissue during cryosurgery. II. Electron microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

In vivo interstitial temperature mapping of the human prostate during cryosurgery with correlation to histopathologic outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

The efficacy and complications of salvage cryotherapy of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Update on cryotherapy for prostate cancer in 2006.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Minimally invasive cryosurgery--technological advances.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Percutaneous, transperineal cryosurgery of the prostate as salvage therapy for post radiation recurrence of adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

PSA elevation during prostate cryosurgery and subsequent decline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Cryosurgery as primary treatment for localized prostate cancer: a community hospital experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Cryosurgical ablation of prostate cancer: patterns of cancer recurrence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Cryosurgery for prostate cancer: new technology and indications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Role of transrectal ultrasound guided salvage cryosurgery for recurrent prostate carcinoma after radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Cryosurgical ablation of the prostate: high risk patient outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Prospective trial of cryosurgical ablation of the prostate: five-year results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Prostate cancer: US-guided percutaneous cryoablation. Work in progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

The current use and future trends of focal surgical therapy in the management of localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate--a 4-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

The "male lumpectomy": focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Current status of local salvage therapies following radiation failure for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Salvage prostate cryoablation after primary interstitial brachytherapy failure: a feasible approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Diagnosis of prostate cancer in needle biopsies after radiation therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Biopsy results after real-time ultrasound-guided transperineal implants for stage T1-T2 prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Multicenter ProstaScint imaging findings in 2154 patients with prostate cancer. The ProstaScint Imaging Centers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Major surgery to manage definitively severe complications of salvage cryotherapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Complications of cryosurgical ablation of the prostate to treat localized adenocarcinoma of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Management of iatrogenic rectourethral fistula

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Percutaneous cryoablation of the prostate: preliminary results after 95 procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Cryosurgical ablation of the prostate: treatment alternative for localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer: quality of life outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Prospective evaluation of sexual function in patients receiving cryosurgery as a primary radical treatment for localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Feasibility of nerve-sparing prostate cryosurgery: applications and limitations in a canine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

Antifreeze proteins: an unusual receptor-ligand interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2009.11.007

10.1016/J.UCL.2009.11.007

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference